CBC Cannabichromene CAS: 20675-51-8

CAS NO: 20675-51-8
CBC Cannabichromene
Chemical Name: cannabichromene
Molecular Formula: C21H30O2
Formula Weight: 314.46
CAS No.: 20675-51-8
Description Review
Description

The scientific community is beginning to recognize cannabichromene (CBC) as a noteworthy cannabinoid because of its special qualities and possible health advantages. CBC, unlike its more well-known cousins THC and CBD, presents an interesting field of research in cannabis science.



Search terms for Google:

Analysis of cannabinoids by CBC, Exploring the medical research on cannabichromene, Comparing the effects of CBC and THC, CBC, a type of non-psychoactive cannabinoid, Exploring the health applications of CBC, The impact of CBC on inflammation Exploring the pharmacology of cannabichromene, Potential therapeutic applications of CBC Safety profile of cannabichromene: Exploring clinical studies conducted by CBC.


Similar Products from Competitors:
Cannabinoids such as CBD (Cannabidiol), CBG (Cannabigerol), and CBN (Cannabinol) vie for market share with CBC, as they each possess distinct properties and prospective medical uses.


Healthy Benefits:
CBC's anti-inflammatory benefits, pain-relieving capabilities, and the possibility that it might promote mental health by lowering stress and depression levels have all prompted research into the compound.


Possible Impacts:
Through a phenomena that is referred to as the "entourage effect," cannabidiol (CBC) is thought to add to the general health advantages of cannabis, despite the fact that it does not produce intoxication as THC does.


Product Workings:
CBC interacts with the body's endocannabinoid system in a different way than THC or CBD. Receptors associated with pain perception and inflammation have been identified as binding sites.


Risks and Adverse Reactions:
According to new study, CBC is safe and doesn't have many side effects, just like other cannabinoids. On the other hand, people's reactions could differ, thus more research is required.


Dosing Info:
Research is currently ongoing to determine the ideal CBC dose. As with any cannabis, it is best to start with modest dosages and gradually increase depending on individual tolerance and reaction.


Avoidance of contraindications:
People who have been hypersensitive to cannabinoids in the past or who are taking medicines that may affect how the body processes cannabinoids should be very careful when using CBC.

In summary:
One interesting and potentially beneficial cannabinoid is cannabichromene (CBC). In spite of the fact that it does not cause the euphoric effects that THC does, the connection that it has with the endocannabinoid system raises the possibility of its usage in therapeutic applications. The medicinal and health benefits of CBC will become clearer as study progresses.

CBC Cannabichromene CAS: 20675-51-8

Other Questions People also Ask:
First question: Does CBC get you "high" as THC does?
A1: No, CBC does not cause a psychoactive 'high' like THC. Different effects are produced by this non-toxic cannabinoid.

Question 2: Can CBC be used to treat pain?
A2: Additional study is necessary to validate the effectiveness of CBC and determine its ideal application in pain treatment, however preliminary studies indicate that it may have pain-relieving characteristics.


Is it permissible to make use of CBC?
A3: Local cannabis laws govern CBC legality. Legal status for CBC is usually the same in areas where cannabinoids such as CBD are allowed.


Q4: What distinguishes CBC from CBD?
A4: Although both cannabidiol (CBC) and cannabidiol (CBD) are non-psychoactive cannabinoids, they vary in chemical composition and potentially cause distinct therapeutic effects through their interactions with the endocannabinoid system.

Pop ten keywords from Google and synonyms:

  1. Cannabichromene
  2. CBC oil
  3. CBC isolate
  4. Non-intoxicating cannabinoid
  5. Phytocannabinoid
  6. Cannabis extract
  7. Cannabinoid therapy
  8. Anti-inflammatory properties
  9. Neuroprotective effects
  10. Pain management
  • CBC cannabinoid research,
  • Cannabichromene therapeutic properties,
  • CBC vs CBD comparison,
  • Non-psychoactive cannabinoids,
  • CBC medicinal benefits,
  • Endocannabinoid system and CBC,
  • CBC anti-inflammatory effects,
  • Cannabichromene in cannabis,
  • CBC cannabinoid studies,
  • CBC ECS interaction.
Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code